Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin/Prednisolone Fixed Combination vs Individual Components in LASIK
NCT01603030Phase 3Unknown
- Sponsor
- Adapt
- Start
- Jun 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin + prednisolone in post-operative inflammation, post-operative infection, sponsored by Adapt. Status: unknown.
02
Drugs
moxifloxacin + prednisolone
03
Conditions
post-operative inflammationpost-operative infection
Beyond the preview
Go deeper on NCT01603030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01603030.